drugset / Trial / NCT01512953

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata

NCT01512953

Phase 4 Unknown 522 enrolled Università degli Studi di Ferrara
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to prospectively assess whether there is an interaction between genetic status in terms of 2C19 activity and residual platelet reactivity after clopidogrel intake in patients who underwent coronary stenting for elective, urgent or emergent intervention.

Timeline

Start
2011-01
Primary completion
2012-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 30 mg